Nelson Peltz’s firm has held a roughly 5% stake in Solventum since the middle of last year. Solventum, which sells healthcare ...

Thermo Fisher Scientific is expanding its life sciences portfolio by acquiring a division of Solventum that provides ...

Shares of Thermo Fisher Scientific Inc. TMO slid 1.16% to $533.29 Wednesday, on what proved to be an all-around mixed trading ...

Trian Fund Management, which beneficially owns about 5% of Solventum (SOLV) and is the company’s largest active shareholder, commented on ...

Trian Fund Management, L.P. (“Trian”), which beneficially owns ~5% of Solventum Corporation (NYSE: SOLV) (“Solventum” or the “Company”) and is the Company’s largest active shareholder, commented on ...

Investing.com -- Activist investor Trian Fund Management is reportedly planning to urge Solventum to separate additional businesses following the company’s $4.1 billion deal to sell its filtration ...

Thermo Fisher Scientific has a market capitalization of about $203.5 billion. Shares (NYSE: TMO) at midday Wednesday were trading around $532, which is near the bottom of their 52-week range.

Solventum's $4.1B divestment to Thermo Fisher enhances financial stability, boosts EPS, and strengthens its long-term growth ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Thermo Fisher (TMO – Research Report), ...

GlobalData analyst Dr Andrew S Thompson expects the deal to prompt a "shuffle" in Thermo Fisher’s life sciences unit.